Skip to main content
. 2020 May 29;10:8776. doi: 10.1038/s41598-020-65215-6

Figure 4.

Figure 4

(a) Overlay of multiple ROC curves for the LMs of Fig. 3a in the CombiROC analysis. (b) Results from the CombiROC analysis for the prediction of EDA status/Non-Response to SFE treatment from baseline LM levels.